Challenges in monitoring vancomycin in outpatient parenteral antimicrobial therapy: opportunities for mitigation utilizing OSHA’s framework for mitigating workplace hazards

2025/01/01 by Dominic C Regli, Seth Warner, Ethan Wilcox +2 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Antibiotics Pharmacokinetics and Efficacy #Antimicrobial Resistance in Staphylococcus #Bacterial Identification and Susceptibility Testing

paper · pdf · doi:10.1017/ash.2025.10052

openalex publication_date 2025/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Discussions

• From @marvinbittner.bsky.social et al: Weaknesses in transitions of care plague outpatient parenteral antimicrobial therapy. OSHA’s framework prioritizes mitigation strategies in this order: eliminati [bsky, 0 points, 0 comments]

Related

• Education and electronic health record implementation–better together? An assessment of compliance of oral vancomycin dosing for Clostridioides difficile infection and the impact of different antimicrobial stewardship interventions
• Antibiotic-exposure guided prevalence screening for vancomycin-resistant Enterococcus: better value for hospitals
• Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
• Development of a semi-automated stewardship approach for prescriber-specific antibiotic consumption report cards
• Resourcing for hospital antibiotic stewardship programs is associated with higher participation in antimicrobial use tracking: a cross-sectional study